Viking Therapeutics jumps following Madrigal trial success
Shares of Viking Therapeutics (VKTX) are jumping after Madrigal Pharmaceuticals (MGDL) announced that its Phase 2 clinical trial in patients with biopsy-proven non-alcoholic steatohepatitis demonstrated...